Silvant Capital Management LLC compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) durante el segundo trimestre, según la compañía en su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). El inversor institucional compró 4.241 acciones del m

Trillium Asset Management LLC adquirió una nueva posición en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) en el segundo trimestre, según la compañía en su divulgación más reciente ante la Comisión de Bolsa y Valores. El inversor institucional adquirió 31.849 acciones de la medi

Vise Technologies Inc. compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) en el segundo trimestre, según su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). El fondo compró 9.112 acciones de la empresa de investigación médica.

Tocqueville Asset Management L.P. compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) en el segundo trimestre, según la compañía en su presentación más reciente ante la Comisión de Bolsa y Valores. El inversor institucional compró 82.830 acciones de la investigación médica

OVERSEA CHINESE BANKING Corp Ltd compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) en el segundo trimestre, según su divulgación más reciente a la Comisión de Bolsa y Valores. El fondo compró 4.000 acciones de la empresa de investigación médica.

one8zero8 LLC compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) durante el segundo trimestre, según la compañía en su divulgación más reciente ante la Comisión de Bolsa y Valores. La firma compró 6.477 acciones de la empresa de investigación médica.

OVERSEA CHINESE BANKING Corp Ltd compró una nueva participación en Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) en el segundo trimestre, según la compañía en su presentación más reciente ante la Comisión de Bolsa y Valores. El inversor institucional compró 6.130 acciones de la empresa médica re

E Fund Management Co. Ltd. bought a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,731 shares of the medical research compa

Fairtree Asset Management Pty Ltd bought a new position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought 5,903 shares of the medical research company

Ceredex Value Advisors LLC bought a new position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 51,619 shares of the medical research company

Edmond DE Rothschild Holding S.A. acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 54,826 shares of the medical research company

Csenge Advisory Group bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,646 shares of the medi

CM Wealth Advisors LLC bought a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,693 shares of the medical research company

Thermo Fisher Scientific Inc. (NYSE:TMO - Get Free Report) VP Lisa Britt sold 11,440 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $613.12, for a total value of $7,014,092.80. Following the sale, the vice president directly owned 14,784 shares in the company, valued at approximately $9,064,366.08. The trade was a 43.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Advisors Capital Management LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 66,082 shares of the medica

Bank of New York Mellon Corp bought a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,938,410 shares of the medical research company

Advisors Preferred LLC bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,100 shares of the medical research comp

The company’s Millersburg facility manufactures single-use equipment, such as sterile bags, containers, and tubing systems used in the biopharmaceutical industry. The Commonwealth has always been a leader in discovery and […]